Efficacy of prophylactic enteral bromocriptine in reducing the neurogenic fever in severe traumatic brain injury patients in the trauma intensive care unit - A randomized placebo-controlled study
Prophylactic bromocriptine did not significantly reduce NF incidence in severe TBI but showed trends toward lower fever severity. Further research with larger cohorts and optimized dosing is warranted.
Authors
- Amrita Rath
- Dharshnee Chetty (ORCID: https://orcid.org/0000-0002-5033-2180)
- Reena Reena (ORCID: https://orcid.org/0000-0003-0185-975X)
- Somsubhra Pal (ORCID: https://orcid.org/0009-0000-7812-4212)
- Mohanraj Rajesh (ORCID: https://orcid.org/0000-0003-2660-2184)
- Ghanshyam Yadav
Institutions
- Rashid Hospital (AE)
- Mohammed Bin Rashid University of Medicine and Health Sciences (AE)
- Institute of Medical Sciences (IN)
- Banaras Hindu University (IN)
Publication Details
- Journal
- International Journal of Critical Illness and Injury Science
- Published
- 2025-04-01
- DOI
- https://doi.org/10.4103/ijciis.ijciis_30_25
- Primary Topic
- Thermal Regulation in Medicine
- Type
- article
- Field-Weighted Citation Impact
- 0.00